Functional protein aggregates: just the tip of the iceberg.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Nanomedicine

• Publication date

  2015-09-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2217/nnm.15.125PMID 26370294
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Solubilization and refolding of inclusion body proteins.

  2015cited by this paper
• Bacterial inclusion body purification.

  2015cited by this paper
• Overexpressed Arabidopsis Annexin4 accumulates in inclusion body-like structures.

  2015cited by this paper
• Insoluble protein applications: the use of bacterial inclusion bodies as biocatalysts.

  2015cited by this paper
• A novel bio-functional material based on mammalian cell aggresomes

  2015cited by this paper
• Topographically targeted osteogenesis of mesenchymal stem cells stimulated by inclusion bodies attached to polycaprolactone surfaces.

  2014cited by this paper
• Improving protein delivery of fibroblast growth factor-2 from bacterial inclusion bodies used as cell culture substrates.

  2014cited by this paper
• Production of functional inclusion bodies in endotoxin-free Escherichia coli

  2014cited by this paper
• Disrupting self-assembly and toxicity of amyloidogenic protein oligomers by "molecular tweezers" - from the test tube to animal models.

  2014cited by this paper
• Recent advances in recombinant protein expression by Corynebacterium, Brevibacterium, and Streptomyces: from transcription and translation regulation to secretion pathway selection

  2013cited by this paper
• Functionalization of 3D scaffolds with protein-releasing biomaterials for intracellular delivery.

  2013cited by this paper
• Inhibiting toxic aggregation of amyloidogenic proteins: a therapeutic strategy for protein misfolding diseases.

  2013cited by this paper
• Supramolecular organization of protein-releasing functional amyloids solved in bacterial inclusion bodies.

  2013cited by this paper
• Active inclusion bodies of acid phosphatase PhoC: aggregation induced by GFP fusion and activities modulated by linker flexibility

  2013cited by this paper
• Bacterial cell factories for recombinant protein production; expanding the catalogue

  2013cited by this paper
• A nanostructured bacterial bioscaffold for the sustained bottom-up delivery of protein drugs.

  2013cited by this paper
• Two-dimensional microscale engineering of protein-based nanoparticles for cell guidance.

  2013cited by this paper
• Unconventional microbial systems for the cost-efficient production of high-quality protein therapeutics.

  2013cited by this paper
• Construction and Application of a Food-Grade Expression System for Lactococcus lactis

  2013cited by this paper
• Bacterial inclusion bodies as potential synthetic devices for pathogen recognition and a therapeutic substance release

  2013cited by this paper
• Aggregation of PolyQ Proteins Is Increased upon Yeast Aging and Affected by Sir2 and Hsf1: Novel Quantitative Biochemical and Microscopic Assays

  2012cited by this paper
• Functional Inclusion Bodies Produced in Bacteria as Naturally Occurring Nanopills for Advanced Cell Therapies

  2012cited by this paper
• Packaging protein drugs as bacterial inclusion bodies for therapeutic applications

  2012cited by this paper
• Bacterial inclusion bodies: an emerging platform for drug delivery and cell therapy.

  2012cited by this paper
• Dynamic reorganization of metabolic enzymes into intracellular bodies.

  2012cited by this paper
• Inclusion bodies as potential vehicles for recombinant protein delivery into epithelial cells

  2012cited by this paper
• Bacterial inclusion bodies: making gold from waste.

  2012cited by this paper
• Bioadhesiveness and efficient mechanotransduction stimuli synergistically provided by bacterial inclusion bodies as scaffolds for tissue engineering.

  2012cited by this paper
• Inclusion bodies of fuculose‐1‐phosphate aldolase as stable and reusable biocatalysts

  2012cited by this paper
• Bacterial expression systems for recombinant protein production: E. coli and beyond.

  2012cited by this paper
• Production, Characterization, and Application of an Organic Solvent-Tolerant Lipase Present in Active Inclusion Bodies

  2012cited by this paper
• Active Protein Aggregates Produced in Escherichia coli

  2011cited by this paper
• Linking amyloid protein aggregation and yeast survival.

  2011cited by this paper
• Nanomaterials: amyloids reflect their brighter side

  2011cited by this paper
• Isolation of Aggresomes and Other Large Aggregates

  2010cited by this paper
• The nanoscale properties of bacterial inclusion bodies and their effect on mammalian cell proliferation.

  2010cited by this paper
• Protein aggregation from inclusion bodies to amyloid and biomaterials.

  2010cited by this paper
• Friendly production of bacterial inclusion bodies

  2010cited by this paper
• Amyloid-Like Protein Inclusions in Tobacco Transgenic Plants

  2010cited by this paper
• Tunable geometry of bacterial inclusion bodies as substrate materials for tissue engineering

  2010cited by this paper
• In Vivo Enzyme Immobilization by Inclusion Body Display

  2010cited by this paper
• Inhibition of aggregate formation as therapeutic target in protein misfolding diseases: effect of tetracycline and trehalose

  2010cited by this paper
• Isolation of biologically active nanomaterial (inclusion bodies) from bacterial cells

  2010cited by this paper
• Isolation of cell-free bacterial inclusion bodies

  2010cited by this paper
• In Brief

  2009cited by this paper
• Microbial factories for recombinant pharmaceuticals

  2009cited by this paper
• Surface Cell Growth Engineering Assisted by a Novel Bacterial Nanomaterial

  2009cited by this paper
• Rehosting of Bacterial Chaperones for High-Quality Protein Production

  2009cited by this paper
• Widespread reorganization of metabolic enzymes into reversible assemblies upon nutrient starvation

  2009cited by this paper
• Faculty Opinions recommendation of Functional amyloids as natural storage of peptide hormones in pituitary secretory granules.

  2009cited by this paper
• Aggregopathy in Neurodegenerative Diseases: Mechanisms and Therapeutic Implication

  2008cited by this paper
• Physiological aggregation of maltodextrin phosphorylase from Pyrococcus furiosus and its application in a process of batch starch degradation to α-d-glucose-1-phosphate

  2008cited by this paper
• Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer’s and Parkinson’s disease brains

  2008cited by this paper
• Amyloid as a Depot for the Formulation of Long-Acting Drugs

  2008cited by this paper
• Engineering inclusion bodies for non denaturing extraction of functional proteins

  2008cited by this paper
• New properties of inclusion bodies with implications for biotechnology

  2008cited by this paper
• A crosslinked inclusion body process for sialic acid synthesis.

  2008cited by this paper
• Production of Nonclassical Inclusion Bodies from Which Correctly Folded Protein Can Be Extracted

  2008cited by this paper
• In situ protein folding and activation in bacterial inclusion bodies.

  2008cited by this paper
• Inclusion bodies: specificity in their aggregation process and amyloid-like structure.

  2008cited by this paper
• Aggresome formation and neurodegenerative diseases: therapeutic implications.

  2008cited by this paper
• Analysis of Single, Purified Inclusions as a Novel Approach to Understand Methamphetamine Neurotoxicity

  2008cited by this paper
• Misfolded proteins partition between two distinct quality control compartments

  2008cited by this paper
• Divergent genetic control of protein solubility and conformational quality in Escherichia coli.

  2007cited by this paper
• Fusion to a pull‐down domain: a novel approach of producing Trigonopsis variabilisD‐amino acid oxidase as insoluble enzyme aggregates

  2007cited by this paper
• The conformational quality of insoluble recombinant proteins is enhanced at low growth temperatures

  2007cited by this paper
• Characterization of Proteins Associated with Polyglutamine Aggregates

  2007cited by this paper
• Recombinant protein solubility—does more mean better?

  2007cited by this paper
• Amyloid-linked cellular toxicity triggered by bacterial inclusion bodies.

  2007cited by this paper
• Stability of biocatalysts.

  2007cited by this paper
• Bioenergy Beads: A Tool for Regeneration of ATP/NTP in Biocatalytic Synthesis

  2006cited by this paper
• Localization of Functional Polypeptides in Bacterial Inclusion Bodies

  2006cited by this paper
• ORFeome cloning and global analysis of protein localization in the fission yeast Schizosaccharomyces pombe

  2006cited by this paper
• Microbial Cell Factories the Chaperone Dnak Controls the Fractioning of Functional Protein between Soluble and Insoluble Cell Fractions in Inclusion Body-forming Cells

  2006cited by this paper
• Aggresome disruption: a novel strategy to enhance bortezomib-induced apoptosis in pancreatic cancer cells.

  2006cited by this paper
• Corrigendum: ORFeome cloning and global analysis of protein localization in the fission yeast Schizosaccharomyces pombe

  2006cited by this paper
• Structural analysis of protein inclusion bodies by Fourier transform infrared microspectroscopy.

  2006cited by this paper
• Nuclear aggresomes form by fusion of PML-associated aggregates.

  2005cited by this paper
• Kinetics of inclusion body formation studied in intact cells by FT‐IR spectroscopy

  2005cited by this paper
• Aggregation as bacterial inclusion bodies does not imply inactivation of enzymes and fluorescent proteins

  2005cited by this paper
• Advanced genetic strategies for recombinant protein expression in Escherichia coli.

  2005cited by this paper
• Correlation of structural elements and infectivity of the HET-s prion

  2005cited by this paper
• Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli

  2005cited by this paper
• Nanoparticles as recyclable catalysts: the frontier between homogeneous and heterogeneous catalysis.

  2005cited by this paper
• Proteasome inhibition and aggresome formation in sporadic inclusion-body myositis and in amyloid-beta precursor protein-overexpressing cultured human muscle fibers.

  2005cited by this paper
• Transcriptional repression and cell death induced by nuclear aggregates of non-polyglutamine protein.

  2005cited by this paper
• Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma.

  2005cited by this paper
• Identification of ubiquitin‐interacting proteins in purified polyglutamine aggregates

  2004cited by this paper
• Recombinant protein folding and misfolding in Escherichia coli

  2004cited by this paper
• Suppression of polyglutamine-induced protein aggregation in Caenorhabditis elegans by torsin proteins.

  2003cited by this paper
• Protein aggregation in recombinant bacteria: biological role of inclusion bodies

  2003cited by this paper
• Proposed pathogenetic cascade of inclusion-body myositis: importance of amyloid-&bgr;, misfolded proteins, predisposing genes, and aging

  2003cited by this paper
• Domain organization and structure–function relationship of the HET‐s prion protein of Podospora anserina

  2003cited by this paper
• The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans

  2002cited by this paper
• Expanded polyglutamine stretches form an 'aggresome'.

  2002cited by this paper
• Soluble polymers as scaffolds for recoverable catalysts and reagents.

  2002cited by this paper
• Hassles with Taking Out the Garbage: Aggravating Aggresomes

  2002cited by this paper
• Identities of Sequestered Proteins in Aggregates from Cells with Induced Polyglutamine Expression

  2001cited by this paper
• Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans.

  2000cited by this paper
• Aggresomes, inclusion bodies and protein aggregation.

  2000cited by this paper

• Non-native genetic configuration of Gluconobacter oxydans dehydrogenases drives 2-keto-L-gulonic acid production in recombinant Escherichia coli.

  2025cites this paper
• Investigating the influence of process parameters on the properties and refolding yield of single-chain variable fragment inclusion bodies.

  2025cites this paper
• Building Up Functional Coiled-Coil-Based Supramolecular Assemblies for Biomedical and Biotechnological Applications.

  2025cites this paper
• Gas-sensing riboceptors

  2024cites this paper
• Proteomic Evidence for Amyloidogenic Cross-Seeding in Fibrinaloid Microclots

  2024cites this paper
• Functionally active cross-linked protein oligomers formed by homocysteine thiolactone

  2023cites this paper
• State-of-the-art and novel approaches to mild solubilization of inclusion bodies

  2023cites this paper
• Inclusion Bodies: Status Quo and Perspectives.

  2023cites this paper
• Nondenaturing Solubilization of Inclusion Bodies from Lactic Acid Bacteria.

  2022cites this paper
• The future of recombinant host defense peptides

  2022cites this paper
• Identification, functional characterization and expression pattern of myeloid differentiation factor 88 (MyD88) in Nibea albiflora.

  2022cites this paper
• Pull-Down Into Active Inclusion Bodies and Their Application in the Detection of (Poly)-Phosphates and Metal-Ions

  2022cites this paper
• Purification of Inclusion Bodies Produced in Bacteria and Yeast.

  2022cites this paper
• Recombinant Protein Production and Purification of Insoluble Proteins.

  2022cites this paper
• Selecting Subpopulations of High-Quality Protein Conformers among Conformational Mixtures of Recombinant Bovine MMP-9 Solubilized from Inclusion Bodies

  2021cites this paper
• Coiled-Coil Based Inclusion Bodies and Their Potential Applications

  2021cites this paper
• Multifunctional antibody-conjugated coiled-coil protein nanoparticles for selective cell targeting.

  2021cites this paper
• Challenges Associated With the Formation of Recombinant Protein Inclusion Bodies in Escherichia coli and Strategies to Address Them for Industrial Applications

  2021cites this paper
• The Biological Potential Hidden in Inclusion Bodies

  2020cites this paper
• Recombinant Protein-Based Nanoparticles: Elucidating Their Inflammatory Effects In Vivo and Their Potential as a New Therapeutic Format

  2020cites this paper
• Exploring the use of leucine zippers for the generation of a new class of inclusion bodies for pharma and biotechnological applications

  2020cites this paper
• High pressure homogenization is a key unit operation in inclusion body processing.

  2020cites this paper
• In Vivo Bactericidal Efficacy of GWH1 Antimicrobial Peptide Displayed on Protein Nanoparticles, a Potential Alternative to Antibiotics

  2020cites this paper
• Monitoring and control strategies for inclusion body production in E. coli based on glycerol consumption.

  2019cites this paper
• Biochemical Characterization of the Flavivirus-resistance Mouse ABCF3 Protein and a Review of the Antibiotic Resistance and Dissemination Mechanisms in Bacteria

  2019cites this paper
• Characterization of the enzymes involved in the diolsynthase pathway in Pseudomonas aeruginosa

  2019cites this paper
• Biochemical characterization of the mouse ABCF3 protein, a partner of the flavivirus-resistance protein OAS1B

  2019cites this paper
• Generation of a fluorescent oncoprotein in soluble form and its delivery into mammalian cells.

  2019cites this paper
• Surface-Bound Gradient Deposition of Protein Nanoparticles for Cell Motility Studies.

  2018cites this paper
• Perspectives of inclusion bodies for bio-based products: curse or blessing?

  2018cites this paper
• Inclusion Body Bead Size in E. coli Controlled by Physiological Feeding

  2018cites this paper
• Bacterial inclusion bodies are industrially exploitable amyloids

  2018cites this paper
• Screening Protein Aggregation in Cells Using Fluorescent Labels Coupled to Flow Cytometry.

  2018cites this paper
• Custom made inclusion bodies: impact of classical process parameters and physiological parameters on inclusion body quality attributes

  2018cites this paper
• A new approach to obtain pure and active proteins from Lactococcus lactis protein aggregates

  2018cites this paper
• Molecular cloning, structural modeling and production of recombinant Aspergillus terreusl. asparaginase in Escherichia coli.

  2018cites this paper
• Bacterial Inclusion Bodies: Discovering Their Better Half.

  2017cites this paper
• Direct Conversion of an Enzyme from Native-like to Amyloid-like Aggregates within Inclusion Bodies.

  2017cites this paper
• Engineering tumor cell targeting in nanoscale amyloidal materials

  2017cites this paper
• Impact of Glycerol as Carbon Source onto Specific Sugar and Inducer Uptake Rates and Inclusion Body Productivity in E. coli BL21(DE3)

  2017cites this paper
• A novel method to recover inclusion body protein from recombinant E. coli fed-batch processes based on phage ΦX174-derived lysis protein E

  2017cites this paper
• Trends in recombinant protein use in animal production

  2017influential citation
• Teaching an old pET new tricks: tuning of inclusion body formation and properties by a mixed feed system in E. coli

  2017cites this paper
• Application of an E. coli signal sequence as a versatile inclusion body tag

  2017cites this paper
• Functional protein-based nanomaterial produced in microorganisms recognized as safe: A new platform for biotechnology.

  2016cites this paper
• Bacterial mimetics of endocrine secretory granules as immobilized in vivo depots for functional protein drugs

  2016cites this paper
• Conformational and functional variants of CD44-targeted protein nanoparticles bio-produced in bacteria

  2016cites this paper
• Functional inclusion bodies produced in the yeast Pichia pastoris

  2016cites this paper